Kazia Therapeutics Limited. Postemployment Benefit Expense Defined Benefit Plans
Kazia Therapeutics Limited. (KZIA) reported Postemployment Benefit Expense Defined Benefit Plans of AUD 1.76 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-07.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2025-11-07
| Period end | Postemployment Benefit Expense Defined Benefit Plans 12 month | Postemployment Benefit Expense Defined Benefit Plans 12 month as first filed |
|---|---|---|
| 2025-06-30 | 1.76M AUD 20-F · filed 2025-11-07 | |
| 2024-06-30 | 2.16M AUD 20-F · filed 2025-11-07 | |
| 2023-06-30 | 2.25M AUD 20-F · filed 2025-11-07 | |
| 2022-06-30 | 1.67M AUD 20-F · filed 2024-11-15 | 1.66M AUD 20-F · filed 2022-10-17 |
| 2021-06-30 | 336.00K AUD 20-F · filed 2023-10-26 | 1.56M AUD 20-F · filed 2021-10-07 |
| 2020-06-30 | 861.00K AUD 20-F · filed 2022-10-17 | 1.53M AUD 20-F · filed 2020-10-22 |
| 2019-06-30 | 1.40M AUD 20-F · filed 2021-10-07 | |
| 2018-06-30 | 2.21M AUD 20-F · filed 2020-10-22 | |
| 2017-06-30 | 4.08M AUD 20-F · filed 2019-10-21 | |
| 2016-06-30 | 2.83M AUD 20-F · filed 2018-10-24 |